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Regulation of CLOCK and MOP4 by Nuclear
Hormone Receptors in the Vasculature:
A Humoral Mechanism to Reset a Peripheral Clock
quently, complexes of mPER and mCRY proteins enter
the nucleus, where they shut off CLOCK:BMAL1-
mediated transcription. At the same time, mPER2 up-
regulates levels of Bmal1 RNA through an as yet unchar-
acterized mechanism leading to the formation of
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CLOCK:BMAL1 heterodimers which drive mPer/mCry2 Department of Pharmacology
transcription and restart the cycle (Kume et al., 1999;3 Howard Hughes Medical Institute and
Shearman et al., 2000). MOP4 (also termed NPAS2)Department of Neuroscience
shares high homology at the amino acid level withUniversity of Pennsylvania School of Medicine
CLOCK (Hogenesch et al., 1997; Zhou et al., 1997) andPhiladelphia, Pennsylvania 19104
like CLOCK, forms heterodimers with BMAL1 (Hogen-
esch et al., 1998), promotes E box activation of genes
such as Per1 and vasopressin, and is negatively regu-Summary
lated by CRY1 and CRY2 (Kume et al., 1999). However,
the low level of MOP4 expression (Hogenesch et al.,Circadian clock genes are expressed in the suprachi-
1998) and lack of expression in the SCN of neonatal andasmatic nucleus and in peripheral tissues to regulate
adult mice (Shearman et al., 1999) has limited consider-cyclically physiological processes. Synchronization of
ation of its involvement in the core circadian feedbackperipheral oscillators is thought to involve humoral
loop.signals, but the mechanisms by which these are medi-
Recently, molecular clocks similar to those operatingated and integrated are poorly understood. We report
in SCN neurons have been uncovered in peripheral tis-a hormone-dependent interaction of the nuclear re-
sues (Zylka et al., 1998) and in immortalized rat-1 fibro-ceptors, RAR and RXR, with CLOCK and MOP4.
blast cell lines (Balsalobre et al., 1998). In peripheralThese interactions negatively regulate CLOCK/MOP4:
tissues, such as the liver, kidney, and heart, circadianBMAL1-mediated transcriptional activation of clock
rhythms in RNA abundance are apparent for each of thegene expression in vascular cells. MOP4 exhibits a
mPer genes, although the phase of oscillation is delayedrobust rhythm in the vasculature, and retinoic acid
3–9 hr relative to the oscillation in the SCN (Zylka et al.,can phase shift Per2 mRNA rhythmicity in vivo and in
1998). Clock gene oscillations are lost in SCN-lesionedserum-induced smooth muscle cells in vitro, providing
animals (Sakamoto et al., 1998). Furthermore, gene os-a molecular mechanism for hormonal control of clock
cillations dampen more rapidly in cultures of peripheralgene expression. We propose that circadian or peri-
tissues than SCN cells in vitro, where they are sustainedodic availability of nuclear hormones may play a criti-
for weeks (Yamazaki et al., 2000). This suggests that thecal role in resetting a peripheral vascular clock.
peripheral oscillations may be driven or synchronized
by the SCN. It has been suggested that the SCN clockIntroduction
may synchronize peripheral clocks via both neural and
hormonal signals (Ishida et al., 1999; Akashi and Nishida,The internal circadian clock is a molecular time-keeping
2000).mechanism that generates a biological rhythm, regu-
Steroid hormones and vitamins regulate diverse de-lating diverse physiological processes such as blood
velopmental and physiological processes by activatingpressure, sleep-wake cycles, and body temperature in
intracellular members of the nuclear receptor superfam-
mammals. The master pacemaker resides in the supra-
ily, which function as ligand-dependent DNA binding
chiasmatic nucleus (SCN) in mammals (Reppert and
transcription factors (Perlmann and Evans, 1997). Reti-
Weaver, 2001). The SCN consists of multiple, autono- noids act through retinoic acid receptors (RAR) and reti-
mous single cell circadian oscillators, that are synchro- noid X receptors (RXR). While RAR binds both all-trans-
nized to fire rhythmically, generating a coordinated, cir- retinoic acid (tRA) and 9-cis-retinoic acid (9cisRA), RXR
cadian, rhythmic output in intact animals (Welsh et al., only binds 9cisRA (Heyman et al., 1992). In contrast to
1995; Liu et al., 1997). steroid receptors which typically function as homodi-
Interacting positive and negative transcriptional- mers, retinoid X receptors (RXRs) form heterodimers
translational feedback loops drive circadian oscillations with numerous members of the family including retinoic
in both Drosophila and mammals. The best-character- acid receptors (RARs), thyroid hormone receptors (TRs),
ized feedback loop, in the mouse, involves the regulation and peroxisome proliferator-activated receptor (PPARs).
of three Period genes (mPER1–3) and two Cryptochrome The DNA binding domain of these receptors provides
genes (mCRY1 and 2) (Reppert and Weaver, 2001). Cur- gene specificity, and the ligand binding domain provides
rently, it is believed that transcription of mPer and mCry the transcriptional regulatory activity in addition to li-
is driven by accumulating CLOCK:BMAL (MOP3) hetero- gand binding specificity (Mangelsdorf and Evans, 1995;
dimers, which, in turn bind to consensus E box elements Perlmann and Evans, 1997).
(King et al., 1997; Darlington et al., 1998; Gekakis et al., Circulating concentrations of some steroids undergo
1998; Hogenesch et al., 1998; Jin et al., 1999). Subse- circadian variability (Tronche et al., 1998; Czeisler and
Klerman, 1999; Muller, 1999). In addition, recent obser-
vations suggest that feeding cycles can entrain periph-4 Correspondence: garret@spirit.gcrc.upenn.edu
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eral clocks independent of light entrainment (Damiola RXR and RARwas observed in mammalian cells (Fig-
ure 1C). No interactions with other nuclear receptorset al., 2000; Stokkan et al., 2001). While the mechanism
remains unknown, examples of hormonal phase-shifting analyzed in the presence or absence of ligand was ob-
served (Figures 1A and 1C), although they were function-of circadian genes in peripheral organs have begun to
emerge (Balsalobre et al., 2000). Together, these obser- ally expressed (Figure 1D and data not shown). Together
these results suggest that RXR and RAR interact withvations suggest that steroid hormones and vitamins may
serve as candidate regulators of peripheral clocks. MOP4 and CLOCK in intact yeast and mammalian cells
and that these interactions are stimulated by the pres-We were interested in addressing the underlying
mechanisms which regulate peripheral clocks in the vas- ence of cognate nuclear receptor ligands.
In agreement with cell-based assays (Figure 1), in vitroculature. Although molecular evidence of a vascular
clock was not extant, there is circumstantial evidence binding assays also showed nuclear receptor ligands
stimulated the interaction of both MOP4 and CLOCK butthat it may exist. For example, blood pressure under-
goes a marked circadian variability, which is increased not BMAL1, with GST-RXR and GST-RAR-glutathione
sepharose affinity matrices (Figure 2A). To further inves-in patients with hypertension (Millar-Craig et al., 1978;
Panza et al., 1991) and coincides with a temporal vari- tigate the role of ligand in the interaction we utilized
C-terminally truncated AF2 mutants RXR443 andability in the incidence of acute vascular events, such as
myocardial infarction, sudden cardiac death, and stroke RAR404 (Schulman et al., 1996), which are defective
in ligand-dependent function, in the interaction assays.(Marshall, 1977; Tsementzis et al., 1985; Ridker et al.,
1990). Additional to the variability in blood pressure, we Consistent with the ability of ligand to enhance complex
formation, these mutant receptors were unable to formhave previously described a circadian variability in the
local vascular response to pressor hormones (Hoss- complexes with CLOCK and MOP4 (Figure 2B).
The ability of BMAL1 to heterodimerize with bothmann et al., 1980).
Here we demonstrate the presence of a molecular MOP4 and CLOCK prompted us to address what effect
the presence of BMAL1 would have on their interactionclock in the vasculature and identify a mechanism that
would account for synchronization of this clock by circu- with nuclear receptors. While BMAL1 does not bind to
RXR, it did not significantly diminish the ability of MOP4lating humoral signals. We report that the retinoid recep-
tors, RXR and RAR, can interact with MOP4 and to interact with RXR (Figure 2C, lanes 4 and 5). The
addition of unlabeled MOP4 to the BMAL1-GSTRXRCLOCK, in a hormone-dependent manner. Furthermore,
these nuclear hormone receptors inhibit CLOCK:BMAL1 binding reaction facilitated retention of BMAL1, sug-
gesting that MOP4, BMAL1, and RXR may exist as aand MOP4:BMAL1 heterodimer-mediated expression of
circadian responsive genes. Finally, we show that MOP4 trimeric complex in vitro (Figure 2C, lane 6). Even at
limiting amounts of MOP4, the presence of BMAL1 diddisplays a robust cyclical expression pattern in the vas-
culature and demonstrate that retinoic acid can phase- not prevent its association with GSTRXR (Figure 2D).
Thus, BMAL1 does not significantly alter the affinity ofshift Per2 oscillations, suggesting a role for nuclear re-
ceptor-mediated humoral signaling in the regulation of MOP4 for RXR. Similar results were also obtained for
CLOCK (data not shown). Additionally, incubation ofa peripheral clock in the vasculature.
anti-CLOCK or anti-RAR antibodies with in vitro trans-
lated CLOCK and RAR led to the coimmunoprecipia-Results
tion of CLOCK and RAR in a ligand-enhanced manner
(Figure 2E, panels I and II). Furthermore, in vivo ligand-Identification of MOP4 and CLOCK as Retinoid
dependent association between CLOCK and RARReceptor Interacting Proteins
was detected in cell lysates from NIH3T3 cells tran-We identified the bHLH-PAS protein, MOP4, as an RXR
siently cotransfected with expression plasmids encod-interacting clone using the ligand binding domain of
ing hCLOCK and hRAR (Figure 2E, panels III and IV).hRXR as a bait in a two-hybrid screen of a yeast Gal4
Together these results demonstrate that either CLOCKactivation domain (AD) fusion cDNA library from human
or MOP4, free or in its dimeric complex with BMAL1,aortic vascular smooth muscle cells (Figure 1A). We also
can associate with the ligand binding domain (LBD)tested RXR and RAR for possible interactions with
of nuclear receptors in vitro and in vivo in a ligand-full-length cDNAs for MOP4, CLOCK, and BMAL1 be-
enhanced manner.cause of the high homology shared by MOP4 and
CLOCK and the fact that both proteins can heterodimer-
ize with BMAL1. Both RXR and RAR interacted Mapping of the Nuclear Receptor Interaction
Domains of CLOCK and MOP4strongly with CLOCK and MOP4, but not their hetero-
dimeric partner, BMAL1, indicating the specificity of the We generated the N- and C-terminal truncation mutants
of both CLOCK and MOP4 as Gal4BD fusions (Figureinteraction. Similarly, no interaction was observed be-
tween MOP4, CLOCK, or BMAL1 and other nuclear re- 3A) and used them in mammalian two-hybrid assays to
map broadly the nuclear receptor interaction domainceptor constructs which were analyzed (Figure 1A).
A liquid -galactosidase activity assay was utilized to (NRID). While the N-terminal bHLH-PAS domain, which
interacts with BMAL1 (3A, lane 2, panels I and II), showedassess the effect of ligands on these novel interactions.
While RXR and RAR alone interacted with CLOCK no interaction, a very strong interaction between the
C-terminal region (350–824) of MOP4 or CLOCK (370–846)and MOP4, the strength of these interactions was in-
creased up to 15-fold in the presence of ligand (Fig- with RXR and RAR was observed (panels I and II,
lanes 7 and 8). These results localize the NRIDs to theure 1B). Consistent with the yeast two-hybrid results,
CLOCK and MOP4 interaction with VP16 fusions of C termini of MOP4 and CLOCK. For finer mapping, serial
Vascular Clock Regulation by Retinoid Receptors
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Figure 1. Identification of MOP4 and CLOCK
as Retinoid Receptor Interacting Proteins
(A) MOP4 and CLOCK interact with RXR and
RAR in yeast. Three independent YRG2
clones containing Gal4AD fusions of MOP4,
CLOCK, or BMAL1 transformed with Gal4BD
fusions of RXR, PPAR, RAR, LXR, MOP4,
CLOCK, or BMAL1 were patched onto mini-
mal media lacking Trp, Leu, and His and as-
sessed for their ability to grow.
(B) Retinoid receptor ligands increase the in-
teraction of MOP4 and CLOCK with RXR
and RAR in YRG2 cells. Liquid -galactosi-
dase assays of YRG2 clones containing
Gal4BD fusions of RXR or RAR ligand bind-
ing domains and Gal4AD fusions of MOP4,
CLK, or BMAL1 are shown. All-trans retinoic
acid (tRA, 1 M), in the case of RAR, and
9-cis-retinoic acid (9cisRA, 1 M), in the case
of RXR, were added where indicated.
(C) CLOCK and MOP4 interact with RXR and
RAR in a ligand-dependent fashion in mam-
malian cells. CV-1 cells were transiently
transfected with the reporter construct
pMH100-TK-LUC, and various DNAs as
shown. The ligands referred to in (C) are
15dPGJ2, tRA, 9cisRA, T3 (1 M), and ETYA
(10 M) for PPAR, RAR, RXR, TR, and
PPAR, respectively.
(D) PPAR, TR, RXR, and RAR fused to
the Gal4 DNA binding domain are all tran-
scriptionally active. CV-1 cells were tran-
siently transfected with the reporter construct




Figure 2. Characterization of MOP4/CLOCK:
RXR/RAR Interaction In Vitro
(A) MOP4 and CLOCK interact with RXR and
RAR in a ligand-enhanced fashion. In vitro
translated, 35[S]methionine-labeled MOP4,
CLOCK, and BMAL1 were incubated with glu-
tathione sepharose bead bound GST,
GSTRXR, or GSTRAR  tRA or 9cisRA (1
M). Reaction products were separated by
SDS-PAGE and analyzed by phosphorim-
ager. (B) AF2 mutants of RXR and RAR are
unable to bind MOP4 or CLOCK. 35[S]MOP4
and 35[S]CLOCK were incubated with the indi-
cated GSTRXR and RAR constructs. (C)
MOP4, BMAL1 and RXR can exist in a tri-
meric complex. 35[S]MOP4 or 35[S]BMAL1
(lanes 3 and 4), 35[S]MOP4 and unlabeled
BMAL1 (lane 5) and 35[S]BMAL1 and MOP4
(lane 6) were incubated with GSTRXRLBD.
(D) BMAL1 does not alter the affinity of MOP4
for RXR. Decreasing concentrations of
35[S]MOP4  BMAL1 were incubated with
GSTRXRLBD. All of the reactions in (B), (C),
and (D) were carried out in the presence of
9cisRA (1 M) in the case of RXR or tRA (1
M) in the case of RAR, and all reaction
products were separated by SDS-PAGE and
analyzed by phosphorimager. (E) CLOCK in-
teracts with RAR in vitro and in vivo.
35[S]RAR (panel I) or 35[S]-CLOCK (panel II)
were incubated without (lane 1) or with (lanes
2 and 3) CLOCK and RAR proteins, re-
spectively, immunoprecipitated, and probed
with anti-CLOCK or anti-RAR antibodies as
indicated. Lane 3 in both panels I and II indi-
cates ligand treatment. Lane 4 of each panel
shows 10% input. In panels III and IV, cells
were cotransfected with CMXRAR and
CMXCLOCK and incubated for 48 hr. Cells
were incubated with (panels III and IV) or
without (panel III) tRA (1 M). Cell lysates
were DTSSP-cross-linked, immunoprecipi-
tated, and Western blotted with anti-RAR,
anti-CLOCK or control antibodies (CT) as in-
dicated. Input refers to lysates from the trans-
fected cells which were directly probed with
anti-CLOCK antibodies (panel III, lane 1) or
anti-RAR antibodies (panel IV, lane 1).
C-terminal deletion mutants of MOP4 were generated MOP4 in modulating MOP4-RAR/RXR interactions (Fig-
ure 3B, panel III, lane 2).(Figure 3B, panel I), in vitro labeled, and analyzed for
their ability to interact with nuclear receptors by GST
pulldown assays. MOP4727, but not MOP4624 was Ligand-Bound Nuclear Receptors Block E
Box Binding by CLOCK:BMAL1retained on sepharose beads coupled to a GST fusion
of the ligand binding domain of RXR (Figure 3B, panel and MOP4:BMAL1 Heterodimers
In Drosophila the interaction of CLOCK and CYCLEII). Deletion of aa 665–680 severely reduced the ability
of MOP4 to interact with RXR (Figure 3B, panel III, lane (Drosopohila homolog of BMAL1) with negative regula-
tors PER and TIM does not disrupt the CLOCK/CYCLE3). Together, these assays localized the region of MOP4
necessary for interaction to aa 665–680. Similar analysis heterodimer, but prevents it from binding to an E box
(Lee et al., 1999). We performed EMSA analyses to deter-localized the region of CLOCK necessary for NR interac-
tion to aa 370–509 (Figure 3C, panels I and II). mine how interaction with nuclear receptors might influ-
ence the ability of the heterodimer to bind to an E boxThe region of MOP4 that bound to RXR contained
an LxxLL motif (aa 670–675). LxxLL motifs are present element. The assembly of the bHLH-PAS heterodimer
on the E box consensus sequence (Figures 4A and 4B,in nuclear receptor cofactors and in the LBDs of some
nuclear receptors and are necessary for their interac- lanes 5 and 4 respectively) was severely inhibited in the
presence of RXR or RAR and their cognate ligandstions (Glass and Rosenfeld, 2000; Westin et al., 2000).
We mutated the conserved leucines to alanines in the (Figures 4A, lanes 6–7, 4B, lanes 5–6, and 4C, compare
lanes 2 and 3). These results indicate that interaction ofLxxLL motif of MOP4 to determine its role in nuclear
receptor associations. Mutating these three leucines to liganded RXR or RAR with the MOP4/BMAL1 or the
CLOCK/BMAL1 heterodimer reduces their ability to bindalanines also prevented MOP4 from associating with
GSTRXR, suggesting a novel role for LxxLL motifs of DNA (Figure 4D).
Vascular Clock Regulation by Retinoid Receptors
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Figure 3. Mapping the Nuclear Receptor Interaction Domains of MOP4 and CLOCK
(A) C-terminal regions of MOP4 (panel I) and CLOCK (panel II) interact with RXR and RAR. Liquid -galactosidase assays were performed
with YRG2 cells expressing MOP4, CLOCK, BMAL1, RXR, or RAR as indicated. (B) NR interaction domain of MOP4 maps to aa 665–680.
Panel I illustrates the regions of MOP4 which correspond to the deletion mutants. In vitro translated MOP4, full-length and deletion mutants
(panel II and III) were incubated with GSTRXR as indicated. (C) Panel I illustrates the regions of CLOCK which correspond to the C-terminal
deletion mutants. In panel II, full-length CLOCK and CLOCK truncation mutants were incubated with GSTRXRLBD as indicated. In (B) and
(C), all reactions were carried out in the presence of 9cisRA (1M), separated by SDS-PAGE, and analyzed by phosphorimager.
RXR and RAR Block CLOCK/MOP4:BMAL1- E box-induced gene transcription in intact cells. Both
MOP4:BMAL1 and CLOCK:BMAL1 activate transcrip-Induced Transcription in NIH3T3 Cells
The effect of RXR and RAR on E box binding of MOP4 tion via an E box-dependent mechanism (Kume et al.,
1999). Importantly, consistent with previous interactionand CLOCK is consistent with a role for nuclear recep-
tors in the negative limb of the circadian feedback loop. specificity assays (Figure 1), overexpression of RXR
and RAR, but not PPAR or TR, inhibited MOP4- andWe examined this hypothesis directly by analyzing the
effect of overexpression of the retinoid receptors on CLOCK-mediated luciferase reporter gene activation in
Cell
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Figure 4. Ligand-Bound RXR and RAR
Prevent MOP4/CLOCK:BMAL1 Heterodimers
from Binding to a Consensus E Box Element
(A and B) Interaction of MOP4:BMAL1 or
CLOCK:BMAL1 with a radiolabeled E box ele-
ment is inhibited in the presence of ligand-
bound RXR or RAR, respectively. EMSA
analysis was performed using the radiola-
beled consensus E box response element
and unprogrammed lysate, or in vitro trans-
lated, unlabeled proteins as indicated. Bind-
ing of MOP4:BMAL1 or CLOCK:BMAL1 di-
mers to the E box was assayed in the
presence of increasing concentrations of
RXR (A, lanes 6 and 7) or RAR (B, lanes
5 and 6) along with their respective ligands,
9cisRA, and tRA (both at 1 M).
(C) Inhibition of the MOP4:BMAL1 hetero-
dimer/E box interaction by RXR is a ligand-
dependent event. EMSA analysis was per-
formed using the radiolabeled consensus E
box response element and the MOP4:BMAL1
heterodimer. RXR was included in the bind-
ing reaction  (lane 2) and  (lane 3) 9cisRA
(1 M).
(D) Results from each of three separate ex-
periments from (A), (B), and (C) were quanti-
tated by phosphorimager analysis and Im-
ageQuant software. The inhibition of the
MOP4/CLOCK:BMAL1 heterodimer binding
to the radiolabeled E box by ligand-bound RXR
or RARwas calculated and is shown in pan-
els I–III and expressed as % inhibitionSEM.
a dose- and ligand-dependent fashion (Figures 5A, 5B, does not display a robust rhythm in the SCN of mice
(Shearman et al., 1999). Ribonuclease protection analy-5C, and 5D). Finally, we analyzed the effects of RXR
on the ability of mutant forms of MOP4 to activate re- sis was performed after serum shock to determine
whether Mop4 expression fluctuates rhythmically in vas-porter gene expression (Figure 5E). As expected,
MOP4727 and MOP4665-680 retained the ability to ac- cular smooth muscle cells (Balsalobre et al., 1998). Mop4
mRNA expression cycled in a circadian pattern withtivate fully the reporter in the presence of BMAL1 (Fig-
ure 5E, lanes 3 and 7), while MOP4624 and MOPAAA peaks at 28 and 52 hr in VSMC, consistent with it having
a putative role in a vascular clock (Figure 6B, panels Iwere roughly 30% less effective (Figure 5E, lanes 5 and
9). MOP4727 remained susceptible to inhibition by and II). However, in agreement with a previous report
(Shearman et al., 1999), Clock did not display a rhythmicRXR, which is consistent with this mutant having an
intact NRID (Figure 5E, lane 4). In contrast, MOP4624, expression profile (Figure 6B, panel II).
After establishing that Mop4 cycles in hVSMC in cul-MOP4665-680 and MOP4AAA, which showed signifi-
cantly reduced interaction with RAR and RXR, were ture following serum shock, we next examined whether
such an oscillation occurs in VSM in the whole animal.significantly less sensitive to nuclear receptor-mediated
inhibition (Figure 5E, lanes 6, 8, and 10 respectively). Aortae were harvested at 4 hr intervals over a 48 hr
period from balb/c mice maintained either in 12 hr:12Such diminution of the inhibitory effects of RXR, in the
absence of the NR interaction domain in MOP4, are hr light:dark (LD) cycles or in constant darkness (DD).
RNA was extracted from these aortae and analyzed forconsistent with the GST-pulldown assay results and in-
dicate that the carboxyl terminus of MOP4 is necessary the temporal expression profile of Mop4. Mop4 mRNA
was observed to exhibit a robust cyclical expressionfor its interaction with nuclear receptors and for nuclear
receptor-mediated inhibition (Figure 3B). pattern under both LD and DD conditions (Figure 6C,
panels I and III). Per2 expression was also observed
to cycle rhythmically under both conditions (Figure 6C,Clock Genes Are Expressed and Cycle
in the Vasculature panels I and III) but in a pattern antiphase to that of
Mop4. The temporal expression patterns of the clockPrevious reports have demonstrated the expression of
most of the subtypes of RXR and RAR in vascular genes Bmal1, Clock, Cry1 were also analyzed under DD
conditions and mRNA cycling was observed for Bmal1smooth muscle cells (Miano et al., 1996). Strong signals
for Clock, Mop4, Bmal1, and Cry2 were detected in and Cry1 but not Clock (Figure 6C, panels III and IV).
Mop4 and Bmal1 mRNA cycled with a similar phase,vascular smooth muscle cells (Figure 6A). Mop4 was
present in brain tissue and in spinal chord as previously both peaking 8 hr before Per2, which is consistent with
the observation that MOP4:BMAL1 heterodimers drivedescribed (Zhou et al., 1997). Bmal1 expression has
been described to cycle in rat central and peripheral expression of Per2 mRNA (Figure 6C, panels II and IV).
Together these results suggest the existence of a vascu-organs (Oishi et al., 1998), while Clock mRNA reportedly
Figure 5. Overexpression of RXR and RAR Inhibits CLOCK/MOP4:BMAL1-Dependent E Box-Mediated Transcription in NIH3T3 Cells
(A and B) MOP4:BMAL1 and CLOCK:BMAL1 mediated E box transactivation is inhibited by RXR and RAR. NIH3T3 cells were transfected
with pGL3M34-Luc, CMXBMAL1 and either CMXMOP4 or CMXCLOCK alone (A and B, lanes 1 and 2) or together (lane 3) and cotransfected
with CMXRXR (A and B, lanes 4 and 5) or CMXRAR (A and B, lanes 6 and 7).
(C) RXR and RAR inhibition of CLOCK and MOP4 E box transactivation is dose dependent. NIH3T3 cells were transfected as described in
(A) and (B) except that increasing concentrations of RXR (lanes 2–4) or RAR (lanes 6–8) were introduced and incubated in the presence of
ligand. MOP4/CLOCK:BMAL1 activity was normalized relative to the reporter activity (100%) of MOP4:BMAL1 and CLOCK:BMAL1 in the
absence of cotransfected nuclear receptor (lanes 1 and 5).
(D) PPAR and TR do not block MOP4/CLOCK:BMAL1-mediated E box transactivation. Cells were transfected with pGL3M34-Luc,
CMXBMAL1, and either CMXMOP4 or CMXCLOCK (lanes 1 and 4) alone or cotransfected with CMXPPAR (lanes 2 and 5) or CMXTR (lanes
3 and 6). Following transfection, cells were incubated in the presence of 15dPGJ2 or T3 (1 M).
(E) MOP4 NRID mutants are not sensitive to inhibition by ligand-bound RXR. NIH3T3 cells were cotransfected with CMXBMAL1 and CMXMOP4




Figure 6. Analysis of Clock Gene Expression in the Vasculature
(A) Clock genes are expressed in VSMC. Northern blot of human brain, heart, skeletal muscle, vascular smooth muscle cell (VSMC), and spinal
chord poly[A] RNA (3 g) was probed with hMOP4, hBMAL1, hCRY2, hCLOCK, hGAPDH as indicated. Autoradiograph images were digitized
using Adobe Photoshop scanning software.
(B) RPA of hVSMC mRNA following serum shock. The temporal expression profile of hMop4 mRNA after serum shock is represented in panel
I and expressed as Mop4/Actin mRNA signal ratios on the y axis normalized by using the level of hMop4 4 hr after serum shock as 100%.
Panel II shows hVSMC RPA gels analyzed for hMop4, hClock, and h-Actin expression.
(C) mMop4 cycles in vivo in the vasculature. Aortae harvested over 48 hr from balb/c mice maintained in a 12 hr:12 hr LD cycle (panel I) and
from mice in their 2nd and 3rd day of constant darkness (panel III) were analyzed for temporal expression of mMop4, mPer2, mBmal1, mClock,
mCry1, m-Actin. Zeitgeber time (ZT) denotes the entrainment regime with ZT0 	 “lights on” and ZT12 	 “lights off.” The corresponding time
in constant darkness is denoted by circadian time (CT) in panel III. Results from RPA analysis of clock gene expression from three separate
animals were quantitated using ImageQuant software and plotted as target/Actin mRNA signal ratios (panels II and IV) normalized using peak
levels as 100%.
lar clock and provide in vivo evidence which place MOP4 in hVSMC as has been reported in Rat1 and NIH3T3
in the core clock feedback loop in the vasculature. fibroblasts (Balsalobre et al., 1998; Akashi and Nishida,
2000). Following addition of 50% serum for 2 hr, hPer2
mRNA was induced very rapidly at T4 (4 hr after serumRetinoic Acid Phase Shifts PER2 mRNA Rhythms
shock) and entered a cyclical expression pattern, peak-Liganded nuclear receptors interact with CLOCK and
ing at T24 and T48 (Figure 7A, panels I and II). All-trans-MOP4 to prevent their E box-mediated gene activation.
retinoic acid (tRA) was added to the serum induced cellsThis suggests that circadian variability or periodic avail-
at four different time points, T6, T12, T18, and T24 forability in steroid hormones and vitamins, such as reti-
2 hr intervals. Treatment at T12 delayed the hPer2 mRNAnoids, might phase shift or reset a peripheral clock in
from T24 to T28 (Figure 7A, panels I and IIc). tRA treat-the vasculature. We first determined whether oscillating
clock gene expression could be induced by serum shock ment at T6 and T24, however, had no effect on the hPer2
Vascular Clock Regulation by Retinoid Receptors
885
peak (Figure 7A, panels I, IIb, and IIe). The effect of tRA tential importance in both vascular physiology and clini-
cal vascular events.when administered at T18 was similar to treatment at
A novel finding in this study is that MOP4 is an intrinsicT12; the hPer2 peak was phase-shifted by 4 hr and
component of the clock system, at least in the vascula-peaked at T28. Consistent with a 4 hr shift, the second
ture. The expression of MOP4 is reportedly absent incycle peaked at T52 (Figure 7A, panels I and IId). Thus,
the SCN (Shearman et al., 1999), and there are no reportstRA phase delayed the hPer2 oscillation by 4 hr, which
of its cyclical expression, making it difficult to placeis consistent with the observation that ligand bound
MOP4 in the core oscillatory loop. Deletion of the MOP4RXR/RAR prevents the MOP4/CLK:BMAL1 hetero-
gene results in deficits in long-term memory of the cueddimer from activating transcription through its E box.
and contextual fear task (Garcia et al., 2000); this isRemoval of the ligand restored the ability of the MOP4/
interesting, considering reports that conditioned fearCLK:BMAL1 heterodimer to induce Per2 expression, but
may modulate circadian rhythms (Amir and Stewart,the phase of the cycle was delayed.
1998). We now report that MOP4 is strongly expressed inTo address the specificity of this Per2 phase delaying
human vascular smooth muscle cells and in the murineeffect by retinoic acid, the effect of other nuclear hor-
vasculature. MOP4 cycles in the vasculature in vivo un-mone receptor ligands on hPer2 oscillations was subse-
der light/dark conditions and in constant darkness, andquently examined. The synthetic glucocorticoid, dexa-
cycles in vascular smooth muscle cells in vitro aftermethasone, which has been reported to phase shift
serum shock. We show that both MOP4 and CLOCK aremPer2 rhythms in the liver (Balsalobre et al., 2000), was
sensitive to nuclear receptor-mediated inhibition. Theseadded at T18. Dexamethasone treatment phase ad-
observations place MOP4 in the peripheral circadianvanced the hPer2 peak to T20 resulting in the second
feedback loop.peak the following day at T44 rather than T48 (Figure 7B,
The physiological relevance of nuclear receptor-medi-panels I and IIb), which is consistent with the response
ated inhibition of CLOCK and MOP4 transcriptional geneobserved by Schibler and colleagues (Balsalobre et al.,
activation comes from the demonstration that both se-2000), but suggests that the dexamethasone/GR effect
rum-induced and in vivo cycling of Per2 can be phaseon resetting the liver clock may occur by a different mecha-
shifted by a nuclear receptor ligand, depending on thenism. T3 and 15dPGJ2, which are ligands for TR and
time of hormone treatment. Based on our results, wePPAR respectively, had no significant effect on the phase
propose that RXR and RAR play novel roles in theof the hPer2 oscillation (Figure 7B, panels I, IIc, and IId),
negative limb of the circadian feedback loop by bindingwhich is consistent with our in vitro interaction and tran-
to CLOCK and MOP4 and preventing their ability toscriptional activation data (Figures 1 and 5).
drive E box-mediated Per transcription. It remains toWe performed the tRA phase shift experiment in the
be determined whether this effect is restricted to thepresence of cyclohexamide (Figure 7B, panel I), to deter-
periphery or is also operant in the brain. Involvement ofmine whether the effect of ligand-bound RXR and
MOP4 in this peripheral oscillator, but not in the SCNRAR on MOP4/CLOCK function is direct and indepen-
clock, illustrates that some components of the feedbackdent of protein synthesis. VSMC were pretreated with
loop exhibit tissue-specific expression, perhaps facili-cyclohexamide at T17, 1 hr before treatment with tRA.
tating site-specific responses to humoral stimuli. Dexa-Analysis of the hPer2 oscillation demonstrated that
methasone, which has been recently reported to phasecyclohexamide did not prevent tRA from phase delaying
shift the mPer rhythm in peripheral organs (Balsalobre etthe hPer2 oscillation to T28 (Figure 7B, panel I). Cyclo-
al., 2000), phase advances hPer2 in our system, whereashexamide treatment alone had a minimal effect on the
tRA phase delays the Per2 oscillation. These resultsvehicle-treated hPer2 oscillation, slightly delaying the
suggest that glucocorticoids and retinoids may havedrop of the hPer2 peak, which has been previously re-
opposing effects and therefore may utilize differentported (Balsalobre et al., 1998).
mechanisms to reset peripheral clock oscillations.
Finally, mice maintained in constant darkness were
Previous observations have hinted at a circadian role
injected intraperitoneally with tRA to address whether
for retinoid receptors and vitamin A. For example, tar-
it could delay mPer2 oscillations in vivo. tRA dissolved geted disruption of the retinoid-related orphan receptor,
in DMSO or DMSO alone was injected at circadian time ROR, extends the period length (tau) of the free-running
(CT) 9, and hearts and aortae were harvested at CT9, activity rhythm in mice and mildly affects circadian
CT12, CT15, CT18, and CT21. RPA analysis of mPer2 rhythmicity (Andre et al., 1998). Additionally the inter-
levels in retinoic acid-treated animals compared to vehi- photoreceptor retinol binding protein (IRBP) has been
cle- treated animals revealed that the mPer2 peak was shown to undergo circadian variation in zebrafish (Ra-
delayed in both the aorta and heart by 3 hr upon tRA jendran et al., 1996), and recently murine cellular retinol
treatment (Figure 7C). binding protein (mCRBP1), whose function is essential
for vitamin A homeostasis, was observed to be a clock-
Discussion controlled gene in the liver (Zheng et al., 2001). Interest-
ingly, RBP, a retinoid binding protein is a member of
We report a mechanism whereby peripheral circadian the lipocalin protein family which resembles the novel
oscillators may be regulated by humoral factors. This Drosophila takeout (TO) gene superfamily, at least one
involves a novel, ligand-dependent interaction between member of which is controlled by the clock and affects
the retinoid receptors, RXR and RAR, and the bHLH- feeding behavior (Sarov-Blat et al., 2000). Some of these
PAS circadian transcription factors, CLOCK and MOP4, observations indicate a role for retinoids, not only in
which directly affects clock function. This mechanism peripheral circadian physiology, but also in functions
that may be directly controlled by the brain. Our workpertains to a peripheral vascular clock, which is of po-
Cell
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Figure 7. Hormonal Resetting of the Peripheral Clock
(A) Retinoic acid induces a phase delay in the hPer2 rhythm. RPA of hPer2 mRNA in serum-induced hVSMC treated with either vehicle at
T18, or tRA (1 M) at T6, T12, T18, and T24. Panel I shows representative scanned gels analyzed for hPer2 expression after each treatment.
Panels IIa, b, c, d, and e represent vehicle treatment at T18 and tRA treatment at T6, T12, T18, and T24, respectively.
(B) The effect of treatment with dex, 15dPGJ2, T3, and CHX/tRA on the hPer2 rhythm. RPA analysis of hPer2 mRNA in serum-induced hVSMC
treated with either vehicle, dexamethasone (0.1 M), T3 (1 M), 15dPGJ2 (1 M) at T18, or cyclohexamide (CHX) at T17  tRA (1 M) treatment
at T18. Panel I shows representative scanned gels analyzed for hPer2 expression after each treatment. Panels IIa, b, c, and d represent
vehicle, Dex, T3, and 15dPGJ2 treatment at T18, respectively. The relative levels of hPer2 transcripts for treatments shown in (A) and (B),
panel II are calculated as hPer2/Actin mRNA signal ratios on the y axis of each graph using level of hPer2 4 hr after serum shock as 100%.
(C) tRA phase delays the hPer2 rhythm in vivo. Aortae and heart harvested over 12 hr from c57Bl/6 mice maintained in constant darkness
which were intraperitoneally injected at CT9 with tRA (10 mg/kg) dissolved in DMSO or DMSO alone were analyzed for temporal expression
of mPer2 and m-Actin. Representative scanned gels analyzed for mPer2 and mActin expression in aorta and heart after each treatment are
shown.
provides a molecular framework implicating a role for rhythmic signals (Yamazaki et al., 2000). The phase and
amplitude of peripheral clocks vary between differentcirculating steroid hormones and vitamins in vascular
smooth muscle peripheral circadian physiology. tissues and organs, in addition to differing from the
phase and amplitude in the SCN. One of the functionsThe mammalian circadian system is organized such
that self-sustained oscillators in the SCN entrain periph- of a peripheral clock might be to regenerate a weak or
dampened SCN signal, thus amplifying the oscillationeral oscillators by releasing a continuous stream of
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library from human aortic vascular smooth muscle cells (detailedof the signal in that peripheral tissue. A vascular clock
procedure of the library construction is available upon request).may generate an amplified and synchronized vascular
RXR interacting clones were selected on media lacking Trp, Leu,rhythm in response to uncoordinated blood-borne sig-
and His, which contained 10 mM 3-amino-triazol. Surviving colonies
nals from central and peripheral clocks. These signals were assayed for -galactosidase activity using a colony filter lift
may include hemodynamic stress, the diurnal release assay and incubation in the presence of 5-Bromo-4-chloro-3-indolyl
-D-galactoside (X-GAL) as described (Estojak et al., 1995). Theof catecholamines and steroids, or the periodic bioavail-
cDNAs from LacZ positive clones were sequenced across the Gal4/ability of signals, such as vitamins, associated with feed-
library cDNA boundary and analyzed using the BLAST algorithming and metabolic cycling (Damiola et al., 2000; Stokkan
at the NCBI. Liquid -galactosidase assays were carried out aset al., 2001).
described (Estojak et al., 1995).
The existence of multiple oscillators is a common
characteristic of all circadian systems so far described In Vitro Immunoprecipitation and Interaction Assays
in multicellular organisms. Peripheral oscillators permit 35[S]methionine-labeled and unlabeled MOP4, CLOCK, BMAL1, and
all of the MOP4 and CLOCK truncation and deletion mutants andtuning of biological rhythms without difficulty to small,
GSTRXR, GSTRAR, GSTRXR443 or GSTRAR404 were synthe-gradual changes in the phase of the input signal. Dis-
sized and used in GST-pulldown assays as described (Seo et al.,torted environmental cues such as transatlantic air
2001) in the presence and absence of ligands. For IP, 35[S]methio-travel, the changeover from a day to a night work sched-
nine-labeled RAR and CLOCK were incubated with purified CLOCK
ule, or a large hormonal release such as sympatho- and RAR protein and immunoprecipitated using anti-CLOCK and
adrenal activation under conditions of severe stress may anti-RAR antibodies (SantaCruz) as described (Seo et al., 2001).
abolish the phase relationships between SCN and pe-
Coimmunoprecipitationsripheral clocks resulting temporarily in a severely disor-
NIH3T3 cells cotransfected with CMXCLOCK and CMXRAR, treatedganized circadian system.
with tRA (1 M) or vehicle, were lysed as described (Seo et al.,In conclusion, we describe a novel negative regulatory
2001). After centrifugation the supernatant was incubated with
mechanism of the human circadian feedback loop. We cross-linker, DTSSP (final conc. 3 mM, Pierce) at room temperature
report that RXR and RAR can inhibit CLOCK:BMAL1- for 30 min. Anti-Clock, Anti-RAR antibodies or goat-anti-rabbit con-
and MOP4:BMAL1-dependent transcriptional activation trol antibodies were added and coimmunoprecipitation was carried
out as described (Seo et al., 2001) and probed with anti-RAR andof an E box-containing circadian enhancer element. This
anti-CLOCK antibodies, respectively.is evidence of a direct, receptor-mediated negative
regulation of the core clock oscillator. These findings
EMSA Assayshould establish a paradigm for identifying other recep-
A double-stranded 32[P]-labeled consensus oligonucleotide, GGGA
tor-mediated, clock regulatory events in peripheral or- CACGTGACCC (Annovis Inc.) was incubated for 30 min at 4
C in a
gans and suggest that circulating steroids and vitamins buffer containing 150 mM KCl, 20 mM Tris-HCl, pH 7.6, 5 mM MgCl2,
may play a critical role in normal and abnormal vascular and 200 ng poly(dI-dC) in the presence of in vitro translated MOP4,
CLOCK, BMAL1 and RXR or RAR in the presence of 1 M tRAphysiology.
or 1M 9cisRA (Sigma Chemicals) where indicated. The samples
were loaded directly onto 4% polyacrylamide-TBE gels and complexExperimental Procedures
formation analyzed by phosphorimager.
Plasmids and Proteins
Transfection Studies and Mammalian Two-Hybrid AnalysisFor yeast, bacterial, and eukaryotic expression constructs of MOP4,
NIH3T3 cells were seeded at 20,000 cells/well of a 48-well dish asCLOCK, BMAL1, PER2, CRY2, and all of the nuclear receptor con-
described (Seo et al., 2001) with internal control pRLSV40 (5 ng),structs the appropriate PCR-amplified fragments were cloned into
pGL3M34 reporter, CMXMOP4 (100 ng) or CMXCLOCK (100 ng) andpBDGal4, pADGal4 (Stratagene), pGEX4T (Amersham Pharmacia
CMXBMAL1 (100 ng) in the presence or absence of CMXRXR,Molecular Dynamics), CMX-PL1, CMXGal4, pCDNA3.1 and pCRII
CMXRAR (25 ng-100 ng), CMXPPAR, or CMXTR. CMXMOP4-vectors (Invitrogen). Full-length cDNAs for MOP4, MOP3, CLOCK
AAA (100 ng), pCDNA3.1MOP4727 (100 ng), pCDNA3.1-were kindly provided by Dr J. Hogenesch, hNPAS2 is a gift from
MOP4624 (100 ng), and CMXMOP4665-680(100 ng) were usedDr. S.L. McKnight and hCRY2 was generously provided by Dr. A.
instead of CMXMOP4 where indicated. tRA, 9cisRA, 3,3,5-Triiodo-Cashmore. pGL3M34-LUC is a gift from Dr. C.A. Bradfield and
L-Tyronine (T3) and 15 deoxy 12- Prostaglandin J2 (15dPGJ2) (allpMH100-TK-Luc is a gift from Drs. R. Evans and B. Forman (Forman
1 M; Sigma Chemicals) were added where indicated. Mammalianet al., 1995). Sequences of all constructs surrounding the cloning
two-hybrid and modified one-hybrid analysis was identical as abovesites were verified by automated sequencing. Recombinant proteins
except that CV-1 cells and the following DNA were used: MH100TK-were expressed in BL(21) (DE53) E. coli cells (Novagen), purified
LUC (100 ng) reporter, CMXGal4DBDMOP4 (20 ng), CMXGal4DBD-using glutathione beads (Amersham Pharmacia Molecular Dynam-
CLOCK (20 ng) in the presence of CMXVP16PPAR (20 ng),ics). MOP4AAA was constructed using the Quick Change Site-
CMXVP16RAR (20 ng), CMXVP16TR (20 ng), CMXRXR (20 ng),Directed Mutagenesis Kit (Stratagene).
or CMXVP16PPAR (20 ng). In addition, CMXGal4 expression con-
structs of RXR, RAR, PPAR, and TR were cotransfected withAnimal Handling and Tissue Harvesting
MH100TK-LUC (100 ng) with the same ligands as above plus8- to 16-week-old balb/c and c57Bl/6 wild-type mice were kept in
5,8,11,14-Eicosatetraynoic Acid (ETYA; 10 M) (Cayman Chemicals)a 12 hr/12 hr light/dark regimen. At indicated time intervals, mice
where indicated. For all the figures, each value is the mean of atwere lightly anesthetized and then exsanguinated. Tissues were
least three independent experiments  SEM. Each experiment in-harvested, immediately flash-frozen in liquid nitrogen, and stored
cluded six replicates from a single assay.at 70
C. Mice were intraperitoneally injected with 10 mg per kg of
body weight (10 mg/kg) of all-trans retinoic acid (tRA) [500 g/ml
in DMSO] (Sigma) or DMSO alone. Animal care was in accordance Northern Analysis
with the Institutional Animal Care and Use Committee guidelines. Polyadenylated (poly[A]) RNA was extracted from hVSMC (AoSMC,
Clonetics, BioWhittaker Inc.) using FastTrack 2.0 kit (Invitrogen).
Brain, spinal chord, heart, and skeletal muscle poly[A] RNA wasYeast Two-Hybrid Analysis
The yeast strain YRG2 (Stratagene), transformed with the yeast ex- purchased from Clontech. Following electrophoretic transfer, the
blots were hybridized with ULTRAhyb hybridization solution (Am-pression plasmid pBDGal4cam (Stratagene) fused to hRXR, was
used to screen a yeast Gal4 activation domain (AD) fusion cDNA bion) and washed. Probes (1 kb) used were hMOP4, hBMAL1,
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hCLOCK, hCRY2, and hGAPDH (Clontech). Blots were exposed at oscillators in peripheral tissues from the central pacemaker in the
suprachiasmatic nucleus. Genes Dev. 14, 2950–2961.80
C to BioMax film with intensifying screens.
Darlington, T.K., Wager-Smith, K., Ceriani, M.F., Staknis, D., Gek-
Serum Shock akis, N., Steeves, T.D.L., Weitz, C.J., Takahashi, J.S., and Kay, S.A.
Human VSMC were cultured following suppliers’ instructions (1998). Closing the circadian loop: CLOCK-induced transcription of
(Clonetics, Biowhittaker Inc.) and plated on 10 cm2 plates (3500 its own inhibitors per and tim. Science 280, 1599–1603.
cells/cm2) 6 days before the experiment and were serum starved Estojak, J., Brent, R., and Golemis, E.A. (1995). Correlation of two-
for 48 hr when they reached confluence. Serum shock was carried hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15,
out as described (Balsalobre et al., 1998); cells were harvested at 5820–5829.
the indicated time points and stored at 80
C.
Forman, B.M., Umesono, K., Chen, J., and Evans, R.M. (1995).
Unique response pathways are established by allosteric interactionsRPA Analysis
among nuclear hormone receptors. Cell 81, 541–550.Total RNAs from cells and mouse tissues were extracted using
Garcia, J.A., Zhang, D., Estill, S.J., Michnoff, C., Rutter, J., Reick,RNAwiz (Ambion) and Trizol (Life Technologies). RT-PCR products
M., Scott, K., Diaz-Arrastia, R., and McKnight, S.L. (2000). Impairedwere prepared for hMOP4, hACTIN, hPER2, hCLOCK, mMOP4,
cued and contextual memory in NPAS2-deficient mice. Science 288,mPER2, mBMAL1, mCRY1, mCLOCK (Reverse Transcription Sys-
2226–2230.tem, Promega; Expand High Fidelity Taq DNA polymerase, Roche
Molecular Biochemicals) using Placenta total RNA (Ambion). The Gekakis, N., Staknis, D., Nguyen, H.B., Davis, F.C., Wilsbacher, L.D.,
RT-PCR products were cloned into pCRII (Dual Promoter TOPO TA King, D.P., Takahashi, J.S., and Weitz, C.J. (1998). Role of the
cloning kit, Invitrogen). Antisense RNA probes were prepared by in CLOCK protein in the mammalian circadian mechanism. Science
vitro transcription of the linearized templates with T7 or SP6 RNA 280, 1564–1569.
polymerase using 32P-labeled UTP (MAXIscript, In vitro transcription Glass, C.K., and Rosenfeld, M.G. (2000). The coregulator exchange
kit, Ambion). RNA from each time point was hybridized with probe in transcriptional functions of nuclear receptors. Genes Dev. 14,
and digested with RNaseA/T1 (RPAIII, Ambion). The samples were 121–141.
separated on a 4% denaturing-polyacrylamide gel (Sequagel sys-
Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele,tem, National Diagnostics), dried, and analyzed by phosphorimager.
G., Evans, R.M., and Thaller, C. (1992). 9-cis retinoic acid is a highThe data were quantitated using ImageQuant version 1.2 software
affinity ligand for the retinoid X receptor. Cell 68, 397–406.(Amersham Pharmacia). All results represent a mean of at least three
Hogenesch, J.B., Chan, W.K., Jackiw, V.H., Brown, R.C., Gu, Y.Z.,independent experiments and are expressed as the ratio of the
Pray-Grant, M., Perdew, G.H., and Bradfield, C.A. (1997). Character-target signal divided by the Actin signal at the same time point
ization of a subset of the basic-helix-loop-helix-PAS superfamilynormalized to peak levels of target (100%).
that interacts with components of the dioxin signaling pathway. J.
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